Diagnostic Methods for Invasive Fungal Infections

Activity Details
  • Credit Amounts:
    • CME: 0.50
    • CNE: 0.40
  • Cost: Free
  • Release: Jun 8, 2018
  • Expires: Jun 7, 2019
  • Estimated Time to Complete:
    30 Minutes
  • System Requirements:
  • Average User Rating:
    ( Ratings)

 

Faculty

Peter G.  Pappas Peter G. Pappas, MD, FACP (Program Chair)
William E. Dismukes Professor of Medicine
Principal Investigator, Mycoses Study Group Education and Research Consortium
Division of Infectious Diseases
University of Alabama at Birmingham
Birmingham, Alabama

Rhett M.  Shirley Rhett M. Shirley, MD
Assistant Professor of Clinical Internal Medicine
University of South Carolina School of Medicine
Infectious Disease Specialist
GHS Greenville Memorial Hospital
Greenville, South Carolina

Needs Statement

Early identification and targeted treatment of invasive fungal infections has been shown to improve survival. Newer diagnostic methods and strategies provide more rapid results than standard culture and may be beneficial in certain patient populations and in resource-limited settings. This activity reviews the benefits and limitations of available tools for diagnosing four different invasive fungal infections—invasive candidiasis, invasive aspergillosis, mucormycosis, and cryptococcal meningitis.

 

Target Audience

This program is designed specifically for infectious disease specialists, internal medicine specialists and other health care professionals involved in the treatment of patients with or at risk for invasive fungal infections. 

 

Objectives

After completing this activity, participants should be better able to:

  • Evaluate the latest diagnostic techniques for invasive fungal infections to ensure early diagnosis and appropriate initiation of treatment

 

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Talem Health. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly provided by Talem Health.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Contact Hours: 0.40

 

Faculty Disclosure

DISCLOSURE POLICY
Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.  

FACULTY
Dr. Pappas has disclosed that he receives grant support from Astellas Pharma US, Inc., Gilead Sciences Inc., IMMY Diagnostics, Mayne Pharma, Amplyx Pharmaceuticals Inc., and Scynexis.
Dr. Shirley has no relevant financial relationships to disclose.
Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.

PLANNING COMMITTEE
Stuart M. Levitz, MD, Course Director, University of Massachusetts Medical School
Carolynn Thomas Jones, DNP, MSPH, BSN, RN, Nurse Advisor, Ohio State University
Carmela Townsend, DNP, MS/MBA, RN, Lead Nurse Planner, Boston University School of Medicine
Joanna Krause, MPH, Grants Manager, Boston University School of Medicine, CME
Erica Rusie, PharmD, Senior Director, Scientific Affairs, Talem Health, LLC
Carrie Noriega, MD, Medical Writer, Talem Health, LLC
Eric VanStone, Principal, Talem Health, LLC

The members of the Planning Committee have no relevant financial relationships to disclose.

 

Acknowledgment

This activity is supported by an educational grant from Astellas Pharma US, Inc.

This activity is being developed in collaboration with the National Rural Health Association.

 

How To Obtain Credit

  • Follow instructions to register or log in with your professional information.
  • Read the entire monograph.
  • Complete and submit the online post-test and evaluation. You must answer the one (1) post-test question correctly to receive CME/CNE credit.
  • A certificate of participation will be available for download/printing immediately following your successful completion of the post-test and evaluation.

 

Contact Us

For questions regarding this CME/CE activity, please contact:
Lauren Wills by phone, 800-913-9370 ext. 705 or email, lwills@talemhealth.com.

Talem Health, LLC
105 Technology Drive, Suite G4
Trumbull, CT  06611

 

Disclaimer

ALL PROGRAMS, ACTIVITIES, AND MATERIALS PROVIDED BY BOSTON UNIVERSITY OFFICE OF CONTINUING MEDICAL EDUCATION OR ITS ASSOCIATES ARE PROVIDED ON THE CONDITION THAT THEY BE USED SOLELY FOR EDUCATIONAL PURPOSES BY QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY OR TALEM HEALTH, LLC BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE CONTINUING MEDICAL EDUCATION PROGRAMS, ACTIVITIES OR MATERIALS. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.

 

Copyright

©Talem Health, LLC 2018.  All Rights Reserved.